An antineoplastic agent used to treat ovarian cancer. It works by inhibiting DNA topoisomerases, type I.
用于小细胞肺癌(SCLC)和一线治疗失败的晚期转移性卵巢癌。
Hospital JP Garrahan, Buenos Aires, CF, Argentina
Charité Campus Virchow Klinikum, Berlin, Germany
GSK Investigational Site, Uppsala, Sweden
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
Mayo Clinic Arizona, Scottsdale, Arizona, United States
Mayo Clinic in Jacksonville, Jacksonville, Florida, United States
Research Center (16), Russia, Russian Federation
Research Centers (8), Ukraine, Ukraine
GSK Investigational Site, Scottsdale, Arizona, United States
Puget Sound Oncology Consortium (PSOC), Seattle, Washington, United States
Virginia Mason Medical Center, Seattle, Washington, United States
University of New Mexico, Albuquerque, New Mexico, United States
University of Alabama at Birmingham, Birmingham, Alabama, United States
University of New Mexico, Albuquerque, New Mexico, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.